Skip to main content
Matthias Karajannis, MD, Pediatric Hematology & Oncology, New York, NY

MatthiasAngelosKarajannisMDMS

Pediatric Hematology & Oncology New York, NY

Pediatric Neuro-Oncology

Chief, Pediatric Neuro-Oncology Service, Memorial Sloan Kettering Cancer Center and Professor of Pediatrics, Weill Cornell Medical College

Overview of Dr. Karajannis

Dr. Matthias Karajannis is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYU Langone Hospitals, and New York-Presbyterian Hospital. He received his medical degree from Freie University Berlin Faculty of Medicine and has been in practice 20 years. Dr. Karajannis accepts several types of health insurance, listed below. He is one of 31 doctors at NYU Langone Hospitals and one of 95 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pediatric Hematology & Oncology. He also speaks multiple languages, including French and German. He has more than 100 publications and over 500 citings.

Education & Training

  • NYU School of Medicine
    NYU School of MedicineM.S., Clinical Investigation, 2007 - 2009
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Pediatric Neuro-Oncology, 2005 - 2006
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2002 - 2005
  • Duke University Hospital
    Duke University HospitalResidency, Pediatrics, 1999 - 2002
  • Freie University Berlin Faculty of Medicine
    Freie University Berlin Faculty of MedicineClass of 1997
  • Gauss Gymnasium
    Gauss GymnasiumAbitur, 1988

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2007 - 2026
  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • NC State Medical License
    NC State Medical License 1999 - 2002
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Clinical Research Award Children's Tumor Foundation, 2011
  • Clinical Trial Award Children's Tumor Foundation, 2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Heterogeneity Within the PF-EPN-B Ependymoma Subgroup  
    Andrew Grossbach, Vijay Ramaswamy, Benjamin Lu, Mariarita Santi, Caterina Giannini, Linda M Liau, Terri S Armstrong, Sarah Leary, Matthias A Karajannis, Kenneth Aldape..., Acta Neuropathologica
  • Clinical Response to Bevacizumab in Schwannomatosis  
    Blakeley J, Schreck KC, Evans DG, Korf BR, Zagzag D, Karajannis MA, Bergner AL, Belzberg AJ, Neurology, 10/22/2014
  • Glioblastoma Multiforme: State of the Art and Future Therapeutics  
    Wilson T, Karajannis MA, Harter DH, Surgical Neurology International, 1/1/2014
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Her2 Amplification or Polysomy Chromosome 17 (PCH17) in Pilocytic Astrocytoma
    Michael Deel M, McLendon R, Becher O, Karajannis M, Wisoff J, Muh C, Schroeder K, Gururangan S, 16th International Symposium on Pediatric Neuro-Oncology, Singapore, 6/1/2014
  • DNA Methylation Profiling identifies New Tumor Subgroups and Aids Diagnostic Accuracy in a Clinical Neuropathology Setting
    Jones DTW, Capper D, Sill M, Hovestadt V, Schweizer L, Lichter P, Zagzag D, Karajannis MA, Aldape KD, Korshunov A, von Deimling A, Pfister S, 16th International Symposium on Pediatric Neuro-Oncology, Singapore, 6/1/2014
  • Molecular Subgroups of Paediatric Ependymoma
    Witt H, Mack S, Jones DTW, Jager N, Bender S, Ryzhova M, Northcott PA, Remke M, Pfaff E, Tzaridis T, Sill M, Benner A, Isserlin R, Milde T, Gupta N, Karajannis M, Fult..., 44th Congress of the International Society of Paediatric Oncology (SIOP), London, UK, 10/1/2012
  • Join now to see all

Lectures

  • Genomics, Personalized Medicine and Acoustic Neuroma 
    Berkeley Heights, NJ - 10/28/2014
  • Everolimus for Vestibular Schwannomas and Meningiomas: Updates from the Phase 2 and Phase 0 Trials 
    Washington, DC - 6/8/2014
  • Chemotherapy 
    Boston, MA - 6/5/2014
  • Join now to see all

Other

  • Tumours of the Central Nervous System: Hemangioblastoma 
    Zagzag D, Weiner H, Karajannis M, Milla S, PubCan: A Public Database of Human Cancers
    http://www.pubcan.org
    1/1/2010

Press Mentions

  • After a Child's Dire Diagnosis, Hope and Uncertainty at the Frontiers of Medicine
    After a Child's Dire Diagnosis, Hope and Uncertainty at the Frontiers of MedicineDecember 6th, 2018

Professional Memberships

Other Languages

  • French, German

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Illinois Blue Advantage HMO
    BCBS Illinois HMO
    BCBS Illinois PPO
    BCBS North Carolina BlueOptions PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Health Care PPO Platinum
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    Healthfirst New York
    HealthLink PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment